STRATA SKIN SCIENCES INC (SSKN)

US86272A3059 - Common Stock

2.95  0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
29.98M
29.84%
36.16M
20.61%
33.358M
-7.75%
33.672M
0.94%
37.476M
11.30%
40.973M
9.33%
EBITDA
YoY % growth
-660K
-34.69%
640K
196.97%
-767K
-219.84%
693.6K
190.43%
5.406M
679.41%
8.986M
66.22%
EBIT
YoY % growth
-4.4M
-7.84%
-4.65M
-5.68%
-6.32M
-35.91%
-6.263M
0.91%
-2.927M
53.26%
499.8K
117.07%
Operating Margin
-14.68%-12.86%-18.95%-18.60%-7.81%1.22%
EPS
YoY % growth
-0.80
38.46%
-1.55
-93.75%
-2.80
-80.65%
-1.07
61.68%
-1.06
1.52%
-0.24
76.83%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.40
63.19%
-0.45
54.61%
-0.20
-566.40%
-0.20
62.66%
-0.21
49.37%
-0.26
43.82%
0.00
100.00%
0.00
100.00%
0.00
100.00%
Revenue
Q2Q % growth
9.207M
48.31%
8.512M
26.03%
9.569M
13.44%
9.515M
8.16%
9.881M
7.32%
9.314M
9.42%
10.458M
9.29%
10.399M
9.29%
10.802M
9.32%
EBITDA
Q2Q % growth
173.4K
-96.06%
306K
118.66%
1.693M
-15.90%
1.469M
-29.54%
1.326M
664.71%
1.122M
266.67%
2.54M
50.03%
2.295M
56.23%
2.132M
60.78%
EBIT
Q2Q % growth
-1.285M
-11.08%
-1.591M
44.92%
-336.6K
30.74%
-703.8K
57.42%
-907.8K
29.37%
-918K
42.31%
479.4K
242.42%
112.2K
115.94%
-71.4K
92.13%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.53
-76.67%
-0.45-0.08-18.09%
Q2 2024
Q2Q % growth
-0.03
95.00%
-0.710.6895.80%
Q1 2024
Q2Q % growth
-1.00
-25.00%
-0.66-0.34-52.00%
Q4 2023
Q2Q % growth
-1.10
-2,100.00%
-0.20-0.90-439.22%
Q3 2023
Q2Q % growth
-0.30 -0.410.1126.47%
Q2 2023
Q2Q % growth
-0.60
-20.00%
-0.56-0.04-6.95%
Q1 2023
Q2Q % growth
-0.80
-14.29%
-0.71-0.09-12.04%
Q4 2022
Q2Q % growth
-0.05
75.00%
-0.500.4590.10%
Q3 2022
Q2Q % growth
-0.30
-50.00%
-0.610.3150.98%
Q2 2022
Q2Q % growth
-0.50
-266.67%
-0.510.011.96%
Q1 2022
Q2Q % growth
-0.70 -0.61-0.09-14.38%
Q4 2021
Q2Q % growth
-0.20
-100.00%
-0.260.0521.57%
Q3 2021
Q2Q % growth
-0.20
50.00%
-0.510.3160.78%
Q2 2021
Q2Q % growth
0.30
160.00%
-0.460.76165.36%
Q1 2021
Q2Q % growth
-0.70
-133.33%
-0.41-0.29-71.57%
Q4 2020
Q2Q % growth
-0.10
-233.33%
-0.270.1763.24%
Q3 2020
Q2Q % growth
-0.40 -0.37-0.03-6.94%
Q2 2020
Q2Q % growth
-0.50 -0.34-0.16-47.07%
Q1 2020
Q2Q % growth
-0.30 -0.540.2444.85%
Q4 2019
Q2Q % growth
-0.03 -0.240.2187.39%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
8.797M
-0.62%
8.707M90K1.03%
Q2 2024
Q2Q % growth
8.435M
2.24%
7.572M863K11.40%
Q1 2024
Q2Q % growth
6.754M
-10.74%
7.05M-296K-4.20%
Q4 2023
Q2Q % growth
6.208M
-41.43%
10.209M-4.001M-39.19%
Q3 2023
Q2Q % growth
8.852M
-5.93%
8.893M-41K-0.46%
Q2 2023
Q2Q % growth
8.25M
-9.44%
8.92M-670K-7.51%
Q1 2023
Q2Q % growth
7.567M
7.49%
7.654M-87K-1.14%
Q4 2022
Q2Q % growth
10.6M
17.00%
10.018M582K5.81%
Q3 2022
Q2Q % growth
9.41M
22.05%
8.254M1.156M14.01%
Q2 2022
Q2Q % growth
9.11M
23.44%
8.301M809K9.75%
Q1 2022
Q2Q % growth
7.04M
20.75%
7.086M-46K-0.65%
Q4 2021
Q2Q % growth
9.06M
34.82%
9.152M-92K-1.01%
Q3 2021
Q2Q % growth
7.71M
37.43%
7.678M32K0.42%
Q2 2021
Q2Q % growth
7.38M
83.13%
6.707M673K10.03%
Q1 2021
Q2Q % growth
5.83M
-13.37%
6.108M-278K-4.55%
Q4 2020
Q2Q % growth
6.72M
-24.49%
6.827M-107K-1.57%
Q3 2020
Q2Q % growth
5.61M
-25.00%
5M610K12.20%
Q2 2020
Q2Q % growth
4.03M
-47.87%
5.236M-1.206M-23.03%
Q1 2020
Q2Q % growth
6.73M
-10.03%
5.989M741K12.37%
Q4 2019
Q2Q % growth
8.9M 8.435M465K5.51%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 27.82% 0% 46.07%
Revenue0% 4.29% 0% 5.55%